Locations:
Search IconSearch

Cancer

Researcher in lab

Prostate Cancer Drug Metabolite May Fuel Cancer Cells

Men with the HSD3B1(1245C) variant metabolize abiraterone differently

650×450-Prostate-Cancer
June 25, 2018/Cancer

Localized Therapy for High-Risk Prostate Cancer Improves Outcomes

13-year retrospective shows evolution of treatment for aggressive disease

Cholesterol

Reducing Cholesterol Could Enhance T-Cell Cancer Immunotherapy

Tc9 cells have less intracellular cholesterol than other T cells

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

17-DDI-3625-Colon-Cancer-CQD
June 13, 2018/Cancer

New Recommendations: Start Screening People at Average Risk for Colorectal Cancer at Age 45

Tips for counseling patients included throughout new guidelines

650×450-Renal-Cell-Carcinoma
June 3, 2018/Cancer/Research

IMmotion151 Reports Encouraging Results

New mRCC medication regimen effective and well tolerated

16-NEU-1934-Ahluwalia-650×450
June 2, 2018/Cancer/Research

Immunotherapy Vaccine Improves Survival Rates in Patients with Glioblastoma

Drug stimulates an immune response to survivin

Metastatic melanoma cells. Image source: National Cancer Institute
June 2, 2018/Cancer/Research

Familial Melanoma Diagnosis Can Signal Higher Risk for Other Cancers

Many genetic alterations were related to other malignancies

BackPage 75 of 86Next

Advertisement

Ad